Venture Capital
Beijing-based neoX Biotech today announced the completion of a US$10 million pre-A round financing co-led by Vision Plus Capital and Sequoia Capital China. Existing investor Morningside Venture Capital also participated. Proceeds oth the round will be mainly used for talent team construction, expansion of high-throughput laboratory, and cooperation in drug development pipelines. neoX Biotech previously […] AI-Driven Biotech Company neoX Raises $10M Pre-A Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.

In this article